Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,572 | 28,964 | 33,020 | 37,743 | 39,799 |
| Marketable Securities | 19,354 | 19,526 | 19,061 | 17,994 | 18,569 |
| TOTAL | $47,426 | $51,042 | $55,168 | $58,723 | $62,020 |
| Non-Current Assets | |||||
| PPE Net | 51 | 50 | 54 | 48 | 44 |
| Other Non-Current Assets | 295 | 334 | 288 | 66 | 101 |
| TOTAL | $346 | $384 | $342 | $114 | $145 |
| Total Assets | $47,772 | $51,426 | $55,509 | $58,836 | $62,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,085 | 2,853 | 2,674 | 2,745 | 3,047 |
| TOTAL | $2,253 | $3,016 | $2,793 | $2,798 | $3,139 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 107 | 151 | 141 | 0 | 0 |
| TOTAL | $107 | $151 | $141 | $N/A | $N/A |
| Total Liabilities | $2,360 | $3,167 | $2,934 | $2,798 | $3,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,869 | 10,869 | 10,857 | 10,857 | 10,857 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -51,059 | -47,897 | -43,151 | -39,283 | -35,902 |
| Other shareholders' equity | -139 | -262 | -300 | -371 | -435 |
| TOTAL | $45,412 | $48,259 | $52,576 | $56,038 | $59,025 |
| Total Liabilities And Equity | $47,772 | $51,426 | $55,509 | $58,836 | $62,164 |